How should patients with unstable angina and non-ST-segment elevation myocardial infarction be managed? A meta-analysis of randomized trials

被引:40
作者
Choudhry, NK
Singh, JM
Barolet, A
Tomlinson, GA
Detsky, AS
机构
[1] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Univ Toronto, Dept Publ Hlth Sci, Toronto, ON, Canada
[6] Univ Hlth Network, Dept Med, Toronto, ON, Canada
[7] Mt Sinai Hosp, Toronto, ON M5G 1X5, Canada
基金
加拿大健康研究院;
关键词
meta-analysis; meta-regression; acute coronary syndromes; unstable angina; acute myocardial infarction; risk stratification; coronary angiography; myocardial revascularization;
D O I
10.1016/j.amjmed.2005.02.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: Patients with unstable angina or non-ST-segment elevation myocardial infarction (MI) may be managed with either an "invasive" or "conservative" strategy. It is unclear which of these strategies is superior. METHODS We identified studies with MEDLINE andd EMBASE searches (1966-September 2003) and by reviewing reference lists. Studies were included if they were randomized controlled trials comparing management strategies for patients in the early post-unstable angina/non-ST-segment elevation MI period and had follow-up data for at least 3 months. RESULTS: Seven trials that randomized a total of 9212 patients were included. The pooled odds ratio (OR) for all-cause mortality was 0.96 (95% confidence interval [CI]: 0.72 to 1.27). The occurrence of fatal or nonfatal re-infarction was reduced with an invasive strategy (OR 0.73; 95% CI: 0.61 to 0.88) as was readmission to hospital (OR 0.67; 95% CI: 0.48 to 0.94). The endpoints of nonfatal MI and the composite of death or nonfatal MI showed nonsignificant trends favoring an invasive strategy. Trials that included a higher proportion of patients with ST-segment depression on admission and trials in which a larger proportion of patients underwent revascularization showed a greater magnitude of benefit for an invasive strategy. CONCLUSION: For patients with unstable angina/non-ST-segment elevation MI, an invasive strategy reduces rates of fatal or nonfatal re-infarction and hospital readmission, but not all-cause mortality, when compared with a noninvasive strategy. These results suggest that an invasive management strategy should be considered for all patients with unstable angina/non-ST-segment elevation MI and perhaps in particular those with ST-segment depression. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:465 / 474
页数:10
相关论文
共 32 条
  • [11] Clarke M., 2001, COCHRANE REV HDB 4 1
  • [12] THE COMBINATION OF ESTIMATES FROM DIFFERENT EXPERIMENTS
    COCHRAN, WG
    [J]. BIOMETRICS, 1954, 10 (01) : 101 - 129
  • [13] de Arenaza DP, 2001, NEW ENGL J MED, V345, P1573
  • [14] METAANALYSIS IN CLINICAL-TRIALS
    DERSIMONIAN, R
    LAIRD, N
    [J]. CONTROLLED CLINICAL TRIALS, 1986, 7 (03): : 177 - 188
  • [15] Economic consequences of routine coronary angiography in low- and intermediate-risk patients with unstable angina pectoris
    Desai, AS
    Solomon, DH
    Stone, PH
    Avorn, J
    [J]. AMERICAN JOURNAL OF CARDIOLOGY, 2003, 92 (04) : 363 - 367
  • [16] DuMouchel WH., 2000, Meta-Analysis in Medicine and Health Policy, P127
  • [17] Bias in meta-analysis detected by a simple, graphical test
    Egger, M
    Smith, GD
    Schneider, M
    Minder, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1997, 315 (7109): : 629 - 634
  • [18] Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial
    Fox, KAA
    Poole-Wilson, PA
    Henderson, RA
    Clayton, TC
    Chamberlain, DA
    Shaw, TRD
    Wheatley, DJ
    Pocock, SJ
    [J]. LANCET, 2002, 360 (9335) : 743 - 751
  • [19] Adjunctive pharmacotherapy for coronary stenting
    Harding, SA
    Walters, DL
    Palacios, IF
    Oesterle, SN
    [J]. CURRENT OPINION IN CARDIOLOGY, 2001, 16 (05) : 293 - 299
  • [20] Cost-effectiveness of an invasive strategy in unstable coronary artery disease -: Results from the FRISC II invasive trial
    Janzon, M
    Levin, LÅ
    Swahn, E
    [J]. EUROPEAN HEART JOURNAL, 2002, 23 (01) : 31 - 40